Levonorgestrel-releasing intrauterine system treatment for endometrial hyperplasia and early endometrial cancer: a systematic review.
Background: Levonorgestrel-releasing intrauterine systems (LNG-IUS) are considered off-label and investigational in the United States for treating non-atypical endometrial hyperplasia (NAEH), atypical endometrial hyperplasia (AEH), and early-stage endometrial cancer (EC), though evidence suggests po...
| Publicado en: | Therapeutic Advances in Reproductive Health Vol. 20; pp. 1 - 27 |
|---|---|
| Autores principales: | , , , , , , , , , , , , , , , |
| Formato: | research systematic review tables/charts Journal Article |
| Publicado: |
Sage Publications Inc.
4/15/2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |